Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indonesia Energy Corporation Limited (INDO) vs GeneDx Holdings Corp (WGS) Price & Performance

Indonesia Energy Corporation LimitedTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Indonesia Energy Corporation Limited vs GeneDx Holdings Corp — how do they compare? Indonesia Energy Corporation Limited trades at $2.97 (market cap $46.01M), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: GeneDx Holdings Corp is far larger — about 39.1× Indonesia Energy Corporation Limited's market cap. Which is the better fit depends on your goals.

INDOWGS
Market Cap
$46.01M$1.80B
Sector
EnergyTechnology
52-Week High
$6.74$167.51
52-Week Low
$2.49$34.51
Enterprise Value
$41.38M$1.80B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Indonesia Energy Corporation Limited

INDO trades at $2.99, down 1.32% today, with a bullish technical outlook supported by positive moving averages and ADX signals. The company is in a high-risk growth phase, reporting a net loss of $5 million on $2 million revenue in 2025, with negative profit margins. Recent news highlights operational progress, including the commencement of drilling at the Kruh Block, which could drive future revenue if successful.

The stock presents speculative upside tied to execution on new oil wells, but carries significant fundamental risk due to current losses and high valuation multiples. Analyst consensus is unanimously bullish, yet investors must weigh potential operational success against the company's fragile financial position and dependence on successful resource extraction.

GeneDx Holdings Corp

GeneDx Holdings (WGS) trades at $60.65, down 4.46% today, amid a bearish technical signal and multiple class-action lawsuits alleging securities fraud. The stock shows weak fundamentals with a negative net income margin of -17.58% and ROE of -30.42%, though it beat EPS estimates in two of the last three quarters. Revenue grew to $427.54M in 2025 but profitability remains a challenge, with a high EV/EBITDA of 161.17 indicating stretched valuation relative to earnings.

Despite a 90.9% analyst buy rating and a $75.40 consensus price target, significant risks from litigation and persistent losses cloud the outlook. The stock faces near-term pressure from legal overhangs, while operational cash flow turned negative in 2026. Investors should weigh high analyst optimism against substantial fundamental and legal headwinds before considering a position.

Returns comparison

Trailing returns across standard periods

About Indonesia Energy Corporation Limited

Indonesia Energy is an oil and gas exploration and production company. It focuses on identifying and developing energy resources in Indonesia, primarily through its Kruh and Citarum blocks.

Read more on INDO

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS